Paillard C, Kanold J, Halle P, Yakouben K, Boiret N, Rapatel C, Berger M, Malpuech G, Deméocq F
Unité Bioclinique de Thérapie Cellulaire et de Transplantation Médullaire, Pédiatrie B, CHU Clermont-Ferrand, France.
Br J Haematol. 2000 Sep;110(4):900-2. doi: 10.1046/j.1365-2141.2000.02281.x.
Life-threatening haemolysis in children with autoimmune haemolytic anaemia (AIHA) occurs rarely. Many cases of severe autoimmune disease are currently treated with immunosuppressive high-dose chemotherapy and autograft. We report here a case of a child with severe AIHA who did not respond to conventional treatments, but was cured with an autologous peripheral blood CD34(+) cell transplantation. After d 16 post autograft, no further red cell transfusions were required. At 20 months post autograft, haematological complete remission persists.